 David Ecker
Concepts (583)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Electrospray Ionization | 46 | 2019 | 180 | 4.430 |
Why?
| | Polymerase Chain Reaction | 50 | 2020 | 1062 | 3.360 |
Why?
| | Molecular Diagnostic Techniques | 11 | 2016 | 105 | 1.480 |
Why?
| | Biosensing Techniques | 5 | 2014 | 129 | 1.470 |
Why?
| | Bacteria | 13 | 2016 | 858 | 1.060 |
Why?
| | Microbiological Techniques | 6 | 2013 | 30 | 1.040 |
Why?
| | DNA, Bacterial | 19 | 2016 | 337 | 0.990 |
Why?
| | Lyme Disease | 6 | 2020 | 60 | 0.970 |
Why?
| | Ixodes | 5 | 2017 | 14 | 0.850 |
Why?
| | Biohazard Release | 1 | 2023 | 1 | 0.840 |
Why?
| | Communicable Diseases, Emerging | 4 | 2008 | 36 | 0.830 |
Why?
| | Viruses | 6 | 2012 | 113 | 0.820 |
Why?
| | Biological Warfare Agents | 2 | 2013 | 3 | 0.820 |
Why?
| | Disease Outbreaks | 5 | 2023 | 395 | 0.790 |
Why?
| | Genotype | 22 | 2019 | 1916 | 0.740 |
Why?
| | Blood | 5 | 2016 | 107 | 0.730 |
Why?
| | Bacterial Typing Techniques | 12 | 2013 | 44 | 0.690 |
Why?
| | Clinical Competence | 2 | 2018 | 1118 | 0.680 |
Why?
| | Sensitivity and Specificity | 19 | 2023 | 1946 | 0.670 |
Why?
| | Borrelia burgdorferi | 5 | 2020 | 19 | 0.670 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 976 | 0.640 |
Why?
| | Bacteremia | 6 | 2015 | 214 | 0.630 |
Why?
| | Drug Design | 5 | 2008 | 167 | 0.620 |
Why?
| | Licensure, Medical | 1 | 2018 | 20 | 0.580 |
Why?
| | Physician Executives | 1 | 2018 | 31 | 0.570 |
Why?
| | Escherichia coli | 14 | 2015 | 815 | 0.520 |
Why?
| | Delivery of Health Care | 1 | 2024 | 951 | 0.520 |
Why?
| | Mass Spectrometry | 11 | 2014 | 739 | 0.520 |
Why?
| | Base Sequence | 30 | 2012 | 2181 | 0.500 |
Why?
| | Anaplasmataceae | 1 | 2015 | 1 | 0.490 |
Why?
| | Population Surveillance | 3 | 2009 | 482 | 0.490 |
Why?
| | Educational Measurement | 1 | 2018 | 289 | 0.470 |
Why?
| | DNA Primers | 14 | 2012 | 515 | 0.460 |
Why?
| | Virus Diseases | 5 | 2014 | 212 | 0.450 |
Why?
| | Hospitals | 2 | 2023 | 691 | 0.450 |
Why?
| | DNA, Fungal | 3 | 2014 | 80 | 0.440 |
Why?
| | Candida | 2 | 2013 | 38 | 0.430 |
Why?
| | Bacteriological Techniques | 6 | 2016 | 73 | 0.430 |
Why?
| | Civil Defense | 1 | 2013 | 19 | 0.420 |
Why?
| | Communicable Diseases | 2 | 2013 | 159 | 0.420 |
Why?
| | Acinetobacter baumannii | 6 | 2012 | 21 | 0.410 |
Why?
| | RNA, Viral | 8 | 2010 | 656 | 0.400 |
Why?
| | Molecular Sequence Data | 25 | 2014 | 2900 | 0.370 |
Why?
| | Biodiversity | 1 | 2015 | 409 | 0.370 |
Why?
| | Point-of-Care Systems | 1 | 2013 | 167 | 0.360 |
Why?
| | Oligodeoxyribonucleotides | 5 | 1998 | 143 | 0.360 |
Why?
| | Thionucleotides | 5 | 1998 | 35 | 0.360 |
Why?
| | Borrelia | 5 | 2014 | 8 | 0.350 |
Why?
| | Respiratory Tract Infections | 4 | 2011 | 390 | 0.350 |
Why?
| | Influenza A virus | 3 | 2011 | 107 | 0.340 |
Why?
| | Acinetobacter Infections | 6 | 2012 | 14 | 0.340 |
Why?
| | Fungemia | 1 | 2010 | 4 | 0.340 |
Why?
| | Humans | 86 | 2024 | 137585 | 0.340 |
Why?
| | Molecular Epidemiology | 3 | 2010 | 68 | 0.330 |
Why?
| | Anti-Bacterial Agents | 7 | 2019 | 1809 | 0.330 |
Why?
| | Computer Simulation | 6 | 2023 | 978 | 0.320 |
Why?
| | Cross Infection | 3 | 2010 | 256 | 0.320 |
Why?
| | Rickettsia | 4 | 2017 | 9 | 0.320 |
Why?
| | Acinetobacter | 4 | 2013 | 13 | 0.310 |
Why?
| | Genetics, Microbial | 1 | 2009 | 10 | 0.310 |
Why?
| | Biological Products | 2 | 2009 | 216 | 0.300 |
Why?
| | Adenoviridae | 2 | 2011 | 193 | 0.290 |
Why?
| | Ubiquitins | 9 | 1994 | 36 | 0.280 |
Why?
| | Drug Discovery | 1 | 2009 | 142 | 0.280 |
Why?
| | Fungi | 6 | 2013 | 144 | 0.280 |
Why?
| | Adenoviridae Infections | 1 | 2007 | 17 | 0.280 |
Why?
| | Oligonucleotides, Antisense | 6 | 1993 | 112 | 0.280 |
Why?
| | Staphylococcus aureus | 7 | 2014 | 450 | 0.280 |
Why?
| | Culex | 1 | 2007 | 16 | 0.270 |
Why?
| | Alphavirus | 1 | 2007 | 21 | 0.270 |
Why?
| | Environmental Microbiology | 1 | 2007 | 53 | 0.270 |
Why?
| | Bacterial Infections | 5 | 2014 | 250 | 0.270 |
Why?
| | Nucleic Acid Conformation | 12 | 2005 | 728 | 0.270 |
Why?
| | Bioterrorism | 3 | 2008 | 30 | 0.270 |
Why?
| | HIV-1 | 6 | 2002 | 864 | 0.270 |
Why?
| | Aedes | 1 | 2007 | 65 | 0.260 |
Why?
| | Antibody Formation | 1 | 2008 | 298 | 0.260 |
Why?
| | Animals | 37 | 2017 | 36940 | 0.250 |
Why?
| | Microbial Sensitivity Tests | 6 | 2015 | 361 | 0.250 |
Why?
| | Base Composition | 6 | 2012 | 78 | 0.250 |
Why?
| | Sequence Alignment | 3 | 2010 | 343 | 0.250 |
Why?
| | Klebsiella pneumoniae | 3 | 2015 | 47 | 0.240 |
Why?
| | 5' Untranslated Regions | 2 | 2004 | 58 | 0.240 |
Why?
| | Coronaviridae Infections | 1 | 2005 | 3 | 0.240 |
Why?
| | Coronaviridae | 1 | 2005 | 3 | 0.240 |
Why?
| | Sentinel Surveillance | 1 | 2005 | 49 | 0.230 |
Why?
| | DNA, Viral | 6 | 2014 | 364 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2023 | 539 | 0.230 |
Why?
| | RNA | 10 | 2010 | 921 | 0.230 |
Why?
| | Chromosome Mapping | 2 | 2004 | 523 | 0.230 |
Why?
| | Tick-Borne Diseases | 3 | 2020 | 10 | 0.220 |
Why?
| | Antiviral Agents | 4 | 1994 | 744 | 0.220 |
Why?
| | Oligonucleotides | 4 | 1997 | 148 | 0.220 |
Why?
| | Candidemia | 2 | 2014 | 11 | 0.220 |
Why?
| | Databases, Factual | 3 | 2008 | 1357 | 0.210 |
Why?
| | Virulence Factors | 1 | 2005 | 167 | 0.210 |
Why?
| | Drug Resistance, Bacterial | 5 | 2013 | 186 | 0.210 |
Why?
| | beta-Lactam Resistance | 2 | 2015 | 8 | 0.210 |
Why?
| | Pharmacology | 1 | 2003 | 9 | 0.200 |
Why?
| | Symbiosis | 2 | 2015 | 79 | 0.200 |
Why?
| | Mycoses | 4 | 2014 | 79 | 0.200 |
Why?
| | Embryonic Development | 1 | 2004 | 119 | 0.200 |
Why?
| | Gene Products, rev | 1 | 2002 | 6 | 0.200 |
Why?
| | Genes, Bacterial | 5 | 2013 | 164 | 0.200 |
Why?
| | Lentivirus | 1 | 2002 | 56 | 0.200 |
Why?
| | Virology | 2 | 2013 | 24 | 0.190 |
Why?
| | Schools, Medical | 1 | 2023 | 147 | 0.190 |
Why?
| | Faculty | 1 | 2023 | 147 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 10 | 1994 | 557 | 0.190 |
Why?
| | Response Elements | 1 | 2002 | 91 | 0.190 |
Why?
| | Oligoribonucleotides | 2 | 1992 | 52 | 0.190 |
Why?
| | Transcription, Genetic | 5 | 2001 | 1457 | 0.190 |
Why?
| | Health Equity | 1 | 2024 | 99 | 0.190 |
Why?
| | Sequence Analysis, RNA | 1 | 2004 | 452 | 0.190 |
Why?
| | Staphylococcal Infections | 3 | 2014 | 400 | 0.190 |
Why?
| | Algorithms | 5 | 2011 | 1704 | 0.190 |
Why?
| | Flaviviridae | 1 | 2001 | 6 | 0.180 |
Why?
| | Central Nervous System Infections | 2 | 2012 | 35 | 0.180 |
Why?
| | Borrelia burgdorferi Group | 1 | 2020 | 9 | 0.180 |
Why?
| | Gene Expression Regulation | 7 | 2004 | 2607 | 0.170 |
Why?
| | Babesia | 2 | 2017 | 3 | 0.170 |
Why?
| | Anaplasma phagocytophilum | 2 | 2017 | 3 | 0.170 |
Why?
| | HIV | 2 | 1992 | 234 | 0.170 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2129 | 0.170 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2011 | 58 | 0.170 |
Why?
| | Behavior, Animal | 1 | 2004 | 501 | 0.170 |
Why?
| | HIV-2 | 2 | 2002 | 18 | 0.160 |
Why?
| | California | 2 | 2015 | 431 | 0.160 |
Why?
| | Benzoates | 1 | 1999 | 43 | 0.160 |
Why?
| | Genetic Techniques | 2 | 2005 | 64 | 0.160 |
Why?
| | Metallothionein | 8 | 1994 | 25 | 0.150 |
Why?
| | Streptococcal Infections | 2 | 2012 | 151 | 0.150 |
Why?
| | Streptococcus pneumoniae | 2 | 2012 | 169 | 0.150 |
Why?
| | Sepsis | 2 | 2016 | 617 | 0.150 |
Why?
| | Ribosomes | 3 | 2005 | 186 | 0.150 |
Why?
| | Sequence Analysis, DNA | 4 | 2015 | 812 | 0.150 |
Why?
| | Quinazolines | 1 | 1999 | 251 | 0.140 |
Why?
| | Tick Infestations | 1 | 2017 | 4 | 0.140 |
Why?
| | RNA, Bacterial | 6 | 2013 | 190 | 0.140 |
Why?
| | Cell Fusion | 2 | 1994 | 51 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2024 | 654 | 0.140 |
Why?
| | HIV Envelope Protein gp120 | 2 | 1994 | 60 | 0.130 |
Why?
| | Pneumonia, Bacterial | 2 | 2015 | 116 | 0.130 |
Why?
| | Evolution, Molecular | 3 | 2012 | 493 | 0.130 |
Why?
| | Communicable Disease Control | 2 | 2008 | 82 | 0.130 |
Why?
| | Glossitis, Benign Migratory | 2 | 2013 | 5 | 0.130 |
Why?
| | Ticks | 3 | 2012 | 25 | 0.130 |
Why?
| | Specimen Handling | 2 | 2015 | 183 | 0.130 |
Why?
| | Structure-Activity Relationship | 5 | 1999 | 570 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2012 | 2189 | 0.120 |
Why?
| | Klebsiella Infections | 2 | 2010 | 26 | 0.120 |
Why?
| | Blood-Borne Pathogens | 1 | 2015 | 7 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 4 | 1997 | 184 | 0.120 |
Why?
| | Nucleosides | 1 | 1995 | 27 | 0.120 |
Why?
| | Phylogeny | 3 | 2015 | 904 | 0.120 |
Why?
| | Models, Biological | 1 | 2003 | 1783 | 0.120 |
Why?
| | Chemistry, Pharmaceutical | 2 | 1995 | 105 | 0.120 |
Why?
| | Cluster Analysis | 3 | 2012 | 499 | 0.120 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.120 |
Why?
| | Models, Chemical | 2 | 1996 | 263 | 0.120 |
Why?
| | Simplexvirus | 2 | 1993 | 80 | 0.110 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 99 | 0.110 |
Why?
| | Babesia microti | 1 | 2014 | 1 | 0.110 |
Why?
| | Species Specificity | 4 | 2012 | 585 | 0.110 |
Why?
| | Streptococcus pyogenes | 2 | 2009 | 45 | 0.110 |
Why?
| | Health Care Reform | 1 | 2015 | 107 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2005 | 239 | 0.110 |
Why?
| | Genes, Fungal | 4 | 1994 | 52 | 0.110 |
Why?
| | Carbapenems | 2 | 2013 | 24 | 0.110 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2013 | 3 | 0.110 |
Why?
| | Statistics as Topic | 2 | 2012 | 307 | 0.110 |
Why?
| | Neoplasms | 1 | 2009 | 2671 | 0.110 |
Why?
| | Serologic Tests | 1 | 2013 | 54 | 0.110 |
Why?
| | Bacterial Proteins | 5 | 2011 | 879 | 0.100 |
Why?
| | Multilocus Sequence Typing | 1 | 2013 | 16 | 0.100 |
Why?
| | Mastitis, Bovine | 1 | 2013 | 2 | 0.100 |
Why?
| | Europe | 4 | 2016 | 414 | 0.100 |
Why?
| | Venous Thrombosis | 1 | 2015 | 190 | 0.100 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 2069 | 0.100 |
Why?
| | Aza Compounds | 1 | 2013 | 14 | 0.100 |
Why?
| | Povidone-Iodine | 1 | 2013 | 11 | 0.100 |
Why?
| | Mycology | 1 | 2013 | 5 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 226 | 0.100 |
Why?
| | Enterovirus | 1 | 2013 | 86 | 0.100 |
Why?
| | Eye Infections, Bacterial | 1 | 2013 | 28 | 0.100 |
Why?
| | Streptococcus intermedius | 1 | 2012 | 1 | 0.100 |
Why?
| | Genes | 3 | 1989 | 230 | 0.100 |
Why?
| | Fusion Proteins, gag-pol | 1 | 1992 | 2 | 0.100 |
Why?
| | DNA | 7 | 2010 | 1459 | 0.100 |
Why?
| | Frameshift Mutation | 1 | 1992 | 32 | 0.100 |
Why?
| | Dirofilariasis | 1 | 2012 | 1 | 0.100 |
Why?
| | Infection Control | 1 | 2014 | 167 | 0.100 |
Why?
| | Ixodidae | 1 | 2012 | 5 | 0.100 |
Why?
| | False Negative Reactions | 1 | 2012 | 53 | 0.100 |
Why?
| | Francisella tularensis | 1 | 2012 | 32 | 0.100 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2013 | 70 | 0.100 |
Why?
| | Milk | 1 | 2013 | 124 | 0.100 |
Why?
| | Diarrhea | 1 | 2013 | 184 | 0.100 |
Why?
| | Limit of Detection | 1 | 2012 | 85 | 0.100 |
Why?
| | Antitubercular Agents | 2 | 2011 | 206 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 1995 | 840 | 0.090 |
Why?
| | RNA, Antisense | 1 | 1991 | 17 | 0.090 |
Why?
| | Virus Replication | 5 | 2005 | 483 | 0.090 |
Why?
| | Quinolines | 1 | 2013 | 178 | 0.090 |
Why?
| | Biological Assay | 1 | 2012 | 124 | 0.090 |
Why?
| | Prostheses and Implants | 1 | 2013 | 143 | 0.090 |
Why?
| | Research Report | 1 | 2012 | 83 | 0.090 |
Why?
| | RNA Caps | 1 | 1991 | 35 | 0.090 |
Why?
| | HIV Long Terminal Repeat | 1 | 1991 | 11 | 0.090 |
Why?
| | Dog Diseases | 1 | 2012 | 64 | 0.090 |
Why?
| | Xenotropic murine leukemia virus-related virus | 1 | 2011 | 1 | 0.090 |
Why?
| | Serotyping | 2 | 2008 | 32 | 0.090 |
Why?
| | Molecular Typing | 1 | 2011 | 22 | 0.090 |
Why?
| | Nucleic Acids | 1 | 2012 | 71 | 0.090 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2011 | 17 | 0.090 |
Why?
| | Hospitals, Military | 2 | 2008 | 25 | 0.090 |
Why?
| | Signal Transduction | 1 | 2004 | 5079 | 0.090 |
Why?
| | Thermodynamics | 6 | 2002 | 407 | 0.090 |
Why?
| | Mycoplasma | 1 | 2010 | 5 | 0.090 |
Why?
| | Military Personnel | 3 | 2006 | 544 | 0.090 |
Why?
| | Male | 20 | 2016 | 67762 | 0.090 |
Why?
| | Nasopharynx | 1 | 2011 | 76 | 0.080 |
Why?
| | Helicobacter | 1 | 2010 | 4 | 0.080 |
Why?
| | Disease Vectors | 1 | 2010 | 16 | 0.080 |
Why?
| | Pyoderma Gangrenosum | 1 | 2010 | 9 | 0.080 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2010 | 37 | 0.080 |
Why?
| | Enterobacteriaceae | 1 | 2010 | 40 | 0.080 |
Why?
| | Middle Aged | 14 | 2016 | 33479 | 0.080 |
Why?
| | Mutation | 5 | 1996 | 3958 | 0.080 |
Why?
| | Flavivirus | 1 | 2010 | 19 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2010 | 32 | 0.080 |
Why?
| | Ehrlichia | 1 | 2009 | 3 | 0.080 |
Why?
| | Ehrlichiosis | 1 | 2009 | 2 | 0.080 |
Why?
| | Feces | 1 | 2013 | 484 | 0.080 |
Why?
| | Agammaglobulinemia | 1 | 2010 | 34 | 0.080 |
Why?
| | beta-Lactamases | 1 | 2010 | 48 | 0.080 |
Why?
| | Medicare | 1 | 2015 | 773 | 0.080 |
Why?
| | Female | 20 | 2016 | 73304 | 0.080 |
Why?
| | Orthopoxvirus | 1 | 2009 | 3 | 0.080 |
Why?
| | Time Factors | 5 | 2015 | 6828 | 0.080 |
Why?
| | Protozoan Infections | 2 | 2008 | 11 | 0.080 |
Why?
| | Mycobacterium | 1 | 2010 | 108 | 0.080 |
Why?
| | Nucleic Acid Hybridization | 6 | 1996 | 190 | 0.080 |
Why?
| | Young Adult | 7 | 2016 | 13209 | 0.080 |
Why?
| | Yeasts | 2 | 2013 | 53 | 0.080 |
Why?
| | Metals | 2 | 1986 | 136 | 0.080 |
Why?
| | Peptide Library | 3 | 1999 | 92 | 0.080 |
Why?
| | Adult | 15 | 2016 | 37929 | 0.070 |
Why?
| | Monte Carlo Method | 4 | 1997 | 148 | 0.070 |
Why?
| | Disulfides | 1 | 1989 | 107 | 0.070 |
Why?
| | Eukaryota | 2 | 2008 | 57 | 0.070 |
Why?
| | Thalassemia | 1 | 2008 | 7 | 0.070 |
Why?
| | Porifera | 1 | 2008 | 8 | 0.070 |
Why?
| | Marine Toxins | 1 | 2008 | 12 | 0.070 |
Why?
| | Chlamydiales | 1 | 2007 | 1 | 0.070 |
Why?
| | United States | 6 | 2018 | 14841 | 0.070 |
Why?
| | Campylobacter | 1 | 2008 | 10 | 0.070 |
Why?
| | Receptor, IGF Type 1 | 1 | 2008 | 65 | 0.070 |
Why?
| | Computational Biology | 2 | 2002 | 644 | 0.070 |
Why?
| | Warfare | 1 | 2008 | 68 | 0.070 |
Why?
| | Aged | 9 | 2016 | 23961 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2011 | 314 | 0.070 |
Why?
| | Adolescent | 11 | 2016 | 21513 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2008 | 115 | 0.070 |
Why?
| | Quinolones | 1 | 2009 | 137 | 0.070 |
Why?
| | Infant | 5 | 2013 | 9465 | 0.070 |
Why?
| | Adenovirus Infections, Human | 1 | 2006 | 15 | 0.070 |
Why?
| | Adenoviruses, Human | 1 | 2006 | 27 | 0.060 |
Why?
| | Genome, Bacterial | 2 | 2012 | 142 | 0.060 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2013 | 549 | 0.060 |
Why?
| | Cancer Vaccines | 1 | 2008 | 172 | 0.060 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2001 | 91 | 0.060 |
Why?
| | Child, Preschool | 5 | 2013 | 11074 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2006 | 78 | 0.060 |
Why?
| | Neuropeptides | 1 | 2006 | 73 | 0.060 |
Why?
| | Plasmids | 5 | 1992 | 363 | 0.060 |
Why?
| | RNA Interference | 1 | 2008 | 469 | 0.060 |
Why?
| | Prevalence | 4 | 2014 | 2734 | 0.060 |
Why?
| | Mice | 9 | 2017 | 17787 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 220 | 0.060 |
Why?
| | Pharmaceutical Preparations | 1 | 2008 | 179 | 0.060 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2005 | 19 | 0.060 |
Why?
| | Forensic Sciences | 1 | 2005 | 6 | 0.060 |
Why?
| | Phospholipases A | 2 | 1996 | 102 | 0.060 |
Why?
| | Huntington Disease | 1 | 2006 | 57 | 0.060 |
Why?
| | DNA Fingerprinting | 3 | 2010 | 26 | 0.060 |
Why?
| | Aged, 80 and over | 6 | 2016 | 7635 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 5 | 1992 | 665 | 0.060 |
Why?
| | Binding Sites | 4 | 2005 | 1303 | 0.060 |
Why?
| | Prospective Studies | 5 | 2016 | 7604 | 0.060 |
Why?
| | Early Diagnosis | 2 | 2016 | 242 | 0.060 |
Why?
| | Genetic Variation | 1 | 2010 | 991 | 0.060 |
Why?
| | Bacillus anthracis | 1 | 2004 | 13 | 0.060 |
Why?
| | Genotyping Techniques | 2 | 2015 | 75 | 0.060 |
Why?
| | Genetic Engineering | 1 | 2005 | 93 | 0.060 |
Why?
| | Benzimidazoles | 1 | 2005 | 170 | 0.060 |
Why?
| | Protein Precursors | 2 | 1999 | 134 | 0.050 |
Why?
| | DNA, Mitochondrial | 1 | 2005 | 200 | 0.050 |
Why?
| | Kinetics | 9 | 1999 | 1670 | 0.050 |
Why?
| | Maze Learning | 1 | 2004 | 103 | 0.050 |
Why?
| | Videotape Recording | 1 | 2023 | 35 | 0.050 |
Why?
| | Hepacivirus | 1 | 2005 | 261 | 0.050 |
Why?
| | RNA, Ribosomal | 2 | 2001 | 168 | 0.050 |
Why?
| | Chemistry | 1 | 2003 | 45 | 0.050 |
Why?
| | Amino Acid Sequence | 5 | 1992 | 2139 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2003 | 83 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 455 | 0.050 |
Why?
| | rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 6 | 0.050 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 19 | 0.050 |
Why?
| | Child | 6 | 2013 | 21935 | 0.050 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 641 | 0.050 |
Why?
| | Genomics | 1 | 2008 | 795 | 0.050 |
Why?
| | Recombinant Proteins | 4 | 2006 | 1353 | 0.050 |
Why?
| | Writing | 1 | 2023 | 95 | 0.050 |
Why?
| | Gene Products, tat | 2 | 1992 | 23 | 0.050 |
Why?
| | Animals, Genetically Modified | 1 | 2003 | 240 | 0.050 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 2 | 1992 | 24 | 0.050 |
Why?
| | Antibodies, Bacterial | 2 | 2013 | 146 | 0.050 |
Why?
| | Rho Factor | 1 | 2001 | 4 | 0.050 |
Why?
| | Primates | 1 | 2002 | 126 | 0.050 |
Why?
| | Cerebrospinal Fluid | 2 | 2012 | 92 | 0.040 |
Why?
| | Minisatellite Repeats | 2 | 2012 | 42 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.040 |
Why?
| | Cell Line | 3 | 2005 | 2847 | 0.040 |
Why?
| | Ohio | 2 | 2012 | 152 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1430 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2001 | 138 | 0.040 |
Why?
| | Models, Molecular | 1 | 2005 | 1570 | 0.040 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3284 | 0.040 |
Why?
| | Encephalitis Viruses, Tick-Borne | 2 | 2010 | 8 | 0.040 |
Why?
| | Critical Illness | 2 | 2016 | 811 | 0.040 |
Why?
| | Point Mutation | 2 | 2009 | 235 | 0.040 |
Why?
| | RNA, Ribosomal, 18S | 1 | 1999 | 26 | 0.040 |
Why?
| | Splanchnic Circulation | 1 | 1999 | 10 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 1999 | 119 | 0.040 |
Why?
| | Enterococcus faecalis | 1 | 1999 | 26 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 389 | 0.040 |
Why?
| | Extracorporeal Circulation | 1 | 1999 | 13 | 0.040 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2009 | 24 | 0.040 |
Why?
| | Calcitonin | 1 | 1999 | 27 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1999 | 132 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 1999 | 433 | 0.040 |
Why?
| | Genetic Markers | 2 | 2012 | 344 | 0.040 |
Why?
| | Mutation, Missense | 2 | 2011 | 341 | 0.040 |
Why?
| | Artiodactyla | 1 | 2017 | 2 | 0.040 |
Why?
| | Czech Republic | 1 | 2017 | 3 | 0.040 |
Why?
| | RNA, Messenger | 5 | 1994 | 2833 | 0.040 |
Why?
| | Sus scrofa | 1 | 2017 | 52 | 0.030 |
Why?
| | Deer | 1 | 2017 | 32 | 0.030 |
Why?
| | Arvicolinae | 1 | 2017 | 32 | 0.030 |
Why?
| | Auranofin | 2 | 1987 | 9 | 0.030 |
Why?
| | Birds | 1 | 2017 | 93 | 0.030 |
Why?
| | Risk Assessment | 2 | 2016 | 3457 | 0.030 |
Why?
| | Anxiety | 1 | 2004 | 1035 | 0.030 |
Why?
| | GTP-Binding Proteins | 2 | 1994 | 161 | 0.030 |
Why?
| | HeLa Cells | 3 | 1993 | 636 | 0.030 |
Why?
| | Sciuridae | 1 | 2017 | 147 | 0.030 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1996 | 89 | 0.030 |
Why?
| | Receptors, Leukotriene B4 | 1 | 1995 | 7 | 0.030 |
Why?
| | Endopeptidases | 3 | 1994 | 90 | 0.030 |
Why?
| | Leukotriene B4 | 1 | 1995 | 42 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 2015 | 48 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1995 | 202 | 0.030 |
Why?
| | Body Fluids | 1 | 2015 | 66 | 0.030 |
Why?
| | Gram-Negative Bacteria | 1 | 2015 | 73 | 0.030 |
Why?
| | Esters | 1 | 1995 | 76 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1994 | 14 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 1993 | 267 | 0.030 |
Why?
| | Biotechnology | 1 | 1995 | 42 | 0.030 |
Why?
| | Arthropod Vectors | 1 | 2014 | 7 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 87 | 0.030 |
Why?
| | Automation, Laboratory | 1 | 2014 | 7 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1995 | 229 | 0.030 |
Why?
| | Zidovudine | 1 | 1994 | 78 | 0.030 |
Why?
| | Germany | 1 | 2014 | 121 | 0.030 |
Why?
| | Mupirocin | 1 | 2014 | 7 | 0.030 |
Why?
| | Methicillin Resistance | 1 | 2014 | 18 | 0.030 |
Why?
| | Fungal Proteins | 1 | 1994 | 123 | 0.030 |
Why?
| | Maryland | 1 | 2014 | 60 | 0.030 |
Why?
| | Tritium | 1 | 1993 | 76 | 0.030 |
Why?
| | Amplified Fragment Length Polymorphism Analysis | 1 | 2013 | 1 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2057 | 0.030 |
Why?
| | Nose | 1 | 2014 | 67 | 0.030 |
Why?
| | Bangladesh | 1 | 2013 | 56 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1325 | 0.030 |
Why?
| | Arizona | 1 | 2013 | 81 | 0.030 |
Why?
| | Africa | 1 | 2013 | 108 | 0.030 |
Why?
| | Fluoroquinolones | 1 | 2013 | 51 | 0.030 |
Why?
| | Corneal Diseases | 1 | 2013 | 35 | 0.030 |
Why?
| | Anti-Infective Agents, Local | 1 | 2013 | 40 | 0.030 |
Why?
| | Endophthalmitis | 1 | 2013 | 29 | 0.020 |
Why?
| | Virulence | 1 | 1994 | 267 | 0.020 |
Why?
| | Gene Library | 1 | 1993 | 118 | 0.020 |
Why?
| | Brain Abscess | 1 | 2012 | 10 | 0.020 |
Why?
| | Cattle | 2 | 2013 | 984 | 0.020 |
Why?
| | Nymph | 1 | 2012 | 6 | 0.020 |
Why?
| | Reticulocytes | 2 | 1989 | 18 | 0.020 |
Why?
| | Cloning, Molecular | 3 | 1989 | 534 | 0.020 |
Why?
| | Genes, ras | 1 | 1992 | 97 | 0.020 |
Why?
| | Ovum | 1 | 2012 | 30 | 0.020 |
Why?
| | Tularemia | 1 | 2012 | 29 | 0.020 |
Why?
| | Rabbits | 2 | 2009 | 794 | 0.020 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2010 | 58 | 0.020 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 95 | 0.020 |
Why?
| | Iron | 2 | 2002 | 313 | 0.020 |
Why?
| | DNA, Ribosomal | 1 | 2012 | 88 | 0.020 |
Why?
| | Ribonuclease H | 1 | 1991 | 12 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 95 | 0.020 |
Why?
| | Antibiotic Prophylaxis | 1 | 2013 | 119 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 1 | 1991 | 32 | 0.020 |
Why?
| | Microbial Viability | 1 | 2012 | 91 | 0.020 |
Why?
| | Adenosine | 1 | 1993 | 225 | 0.020 |
Why?
| | Ligases | 2 | 1989 | 32 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 1998 | 778 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 1989 | 611 | 0.020 |
Why?
| | Larva | 1 | 2012 | 226 | 0.020 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2011 | 3 | 0.020 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2011 | 5 | 0.020 |
Why?
| | Cell Cycle | 1 | 1994 | 601 | 0.020 |
Why?
| | Georgia (Republic) | 1 | 2010 | 4 | 0.020 |
Why?
| | Endemic Diseases | 1 | 2011 | 32 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 345 | 0.020 |
Why?
| | Influenza B virus | 1 | 2011 | 44 | 0.020 |
Why?
| | Pregnancy | 1 | 2004 | 6763 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 413 | 0.020 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2011 | 54 | 0.020 |
Why?
| | New York City | 1 | 2010 | 85 | 0.020 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2011 | 42 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 234 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 1991 | 148 | 0.020 |
Why?
| | Peptide Fragments | 1 | 1994 | 706 | 0.020 |
Why?
| | China | 1 | 2011 | 217 | 0.020 |
Why?
| | Isoniazid | 1 | 2010 | 63 | 0.020 |
Why?
| | Liver | 1 | 1999 | 1943 | 0.020 |
Why?
| | Rifampin | 1 | 2010 | 84 | 0.020 |
Why?
| | Phenotype | 2 | 2009 | 3196 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2011 | 239 | 0.020 |
Why?
| | Flavivirus Infections | 1 | 2010 | 9 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 601 | 0.020 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2010 | 24 | 0.020 |
Why?
| | Rickettsia rickettsii | 1 | 2009 | 1 | 0.020 |
Why?
| | South Africa | 1 | 2010 | 222 | 0.020 |
Why?
| | Culicidae | 1 | 2010 | 37 | 0.020 |
Why?
| | DNA, Protozoan | 1 | 2010 | 32 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1066 | 0.020 |
Why?
| | Water | 1 | 1993 | 460 | 0.020 |
Why?
| | Neisseria meningitidis | 1 | 2009 | 23 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 827 | 0.020 |
Why?
| | West Nile virus | 1 | 2010 | 43 | 0.020 |
Why?
| | RNA, Protozoan | 1 | 2010 | 60 | 0.020 |
Why?
| | Dengue Virus | 1 | 2010 | 52 | 0.020 |
Why?
| | Geography | 1 | 2010 | 200 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2013 | 6079 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2010 | 127 | 0.020 |
Why?
| | DNA Topoisomerase IV | 1 | 2009 | 1 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2009 | 155 | 0.020 |
Why?
| | North America | 1 | 2010 | 313 | 0.020 |
Why?
| | DNA Gyrase | 1 | 2009 | 12 | 0.020 |
Why?
| | Genetic Vectors | 2 | 1988 | 319 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 1991 | 378 | 0.020 |
Why?
| | Cystine | 1 | 1989 | 18 | 0.020 |
Why?
| | Bacterial Toxins | 1 | 2009 | 106 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1483 | 0.020 |
Why?
| | Genetic Loci | 1 | 2010 | 288 | 0.020 |
Why?
| | Molecular Weight | 4 | 1990 | 335 | 0.020 |
Why?
| | Multigene Family | 1 | 1989 | 198 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2008 | 18 | 0.020 |
Why?
| | Government Agencies | 1 | 2008 | 17 | 0.020 |
Why?
| | Cells, Cultured | 2 | 1994 | 4193 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1989 | 127 | 0.020 |
Why?
| | Temperature | 1 | 1991 | 679 | 0.020 |
Why?
| | Campylobacter coli | 1 | 2008 | 1 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 2224 | 0.020 |
Why?
| | Campylobacter jejuni | 1 | 2008 | 12 | 0.020 |
Why?
| | Viral Load | 1 | 2010 | 466 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4030 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1007 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1994 | 1091 | 0.020 |
Why?
| | Promoter Regions, Genetic | 2 | 1994 | 1250 | 0.020 |
Why?
| | Gene Expression | 1 | 1992 | 1502 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2008 | 159 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 352 | 0.020 |
Why?
| | Phosphines | 1 | 1986 | 17 | 0.020 |
Why?
| | Orexins | 1 | 2006 | 6 | 0.020 |
Why?
| | Huntingtin Protein | 1 | 2006 | 13 | 0.020 |
Why?
| | Sequence Homology | 1 | 2006 | 40 | 0.020 |
Why?
| | Enterobactin | 1 | 1986 | 8 | 0.020 |
Why?
| | Oligopeptides | 1 | 1988 | 271 | 0.020 |
Why?
| | Decision Making | 1 | 2013 | 900 | 0.020 |
Why?
| | Serine | 1 | 1986 | 141 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 2005 | 52 | 0.020 |
Why?
| | Protein Conformation | 1 | 1989 | 934 | 0.020 |
Why?
| | Databases, Nucleic Acid | 1 | 2005 | 34 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 1986 | 111 | 0.020 |
Why?
| | Automation | 1 | 2005 | 95 | 0.010 |
Why?
| | Housing | 1 | 2006 | 146 | 0.010 |
Why?
| | Molecular Structure | 2 | 1996 | 489 | 0.010 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 21 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5778 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2004 | 40 | 0.010 |
Why?
| | Ovary | 1 | 1986 | 221 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2031 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 1986 | 385 | 0.010 |
Why?
| | Fibroblasts | 1 | 1989 | 996 | 0.010 |
Why?
| | Signal Recognition Particle | 1 | 2002 | 9 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1994 | 67 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5131 | 0.010 |
Why?
| | Ferritins | 1 | 2002 | 64 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 596 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2006 | 625 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 14 | 0.010 |
Why?
| | Copper | 2 | 1994 | 104 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 891 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2006 | 712 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 145 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2167 | 0.010 |
Why?
| | Pilot Projects | 1 | 2005 | 1710 | 0.010 |
Why?
| | Aminoglycosides | 1 | 1999 | 25 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 10388 | 0.010 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 1999 | 38 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 2 | 1994 | 465 | 0.010 |
Why?
| | Ubiquitin-Activating Enzymes | 2 | 1989 | 17 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3412 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2006 | 3556 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 342 | 0.010 |
Why?
| | Mice, SCID | 1 | 1998 | 367 | 0.010 |
Why?
| | Coronary Artery Bypass | 1 | 1999 | 234 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 1989 | 175 | 0.010 |
Why?
| | Ligands | 1 | 1999 | 664 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1998 | 230 | 0.010 |
Why?
| | Phospholipases A2 | 1 | 1996 | 80 | 0.010 |
Why?
| | Cadmium | 2 | 1987 | 69 | 0.010 |
Why?
| | Cricetinae | 2 | 1987 | 289 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 180 | 0.010 |
Why?
| | Gold | 2 | 1986 | 118 | 0.010 |
Why?
| | Transducin | 1 | 1994 | 42 | 0.010 |
Why?
| | Biomarkers | 1 | 2006 | 4149 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1994 | 96 | 0.010 |
Why?
| | RNA, Fungal | 1 | 1994 | 72 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1993 | 11 | 0.010 |
Why?
| | Methods | 1 | 1993 | 65 | 0.010 |
Why?
| | Cell Survival | 2 | 1987 | 1120 | 0.010 |
Why?
| | Circular Dichroism | 1 | 1993 | 149 | 0.010 |
Why?
| | Bovine papillomavirus 1 | 1 | 1992 | 1 | 0.010 |
Why?
| | Luciferases | 1 | 1992 | 150 | 0.010 |
Why?
| | Codon | 1 | 1992 | 89 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1992 | 139 | 0.010 |
Why?
| | Lysine | 1 | 1994 | 294 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 955 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1992 | 181 | 0.010 |
Why?
| | Cell Membrane | 1 | 1994 | 738 | 0.010 |
Why?
| | Cytokines | 1 | 1999 | 2085 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1990 | 115 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1998 | 1996 | 0.010 |
Why?
| | Butyric Acid | 1 | 1989 | 7 | 0.000 |
Why?
| | Phorbol 12,13-Dibutyrate | 1 | 1989 | 8 | 0.000 |
Why?
| | Chromatography, Ion Exchange | 1 | 1989 | 55 | 0.000 |
Why?
| | Electrophoresis | 1 | 1989 | 32 | 0.000 |
Why?
| | Copper Sulfate | 1 | 1988 | 8 | 0.000 |
Why?
| | Methylation | 1 | 1989 | 230 | 0.000 |
Why?
| | Retrospective Studies | 1 | 2006 | 15657 | 0.000 |
Why?
| | Butyrates | 1 | 1989 | 61 | 0.000 |
Why?
| | Substrate Specificity | 1 | 1989 | 372 | 0.000 |
Why?
| | Membrane Proteins | 1 | 1994 | 1164 | 0.000 |
Why?
| | Hydrolysis | 1 | 1988 | 177 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4295 | 0.000 |
Why?
| | Organogold Compounds | 1 | 1986 | 5 | 0.000 |
Why?
| | Dexamethasone | 1 | 1989 | 368 | 0.000 |
Why?
| | Cell Compartmentation | 1 | 1986 | 52 | 0.000 |
Why?
| | Cricetulus | 1 | 1986 | 109 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1986 | 171 | 0.000 |
Why?
| | Drug Resistance | 1 | 1987 | 169 | 0.000 |
Why?
| | Albumins | 1 | 1986 | 114 | 0.000 |
Why?
| | Spectrum Analysis | 1 | 1986 | 91 | 0.000 |
Why?
| | Tissue Distribution | 1 | 1986 | 332 | 0.000 |
Why?
| | Adenosine Triphosphate | 1 | 1988 | 491 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1986 | 560 | 0.000 |
Why?
| | Sulfhydryl Compounds | 1 | 1986 | 189 | 0.000 |
Why?
| | Amino Acids | 1 | 1987 | 497 | 0.000 |
Why?
| | Polymers | 1 | 1987 | 490 | 0.000 |
Why?
| | Zinc | 1 | 1986 | 297 | 0.000 |
Why?
| | Carrier Proteins | 1 | 1986 | 771 | 0.000 |
Why?
| | Proteins | 1 | 1986 | 1009 | 0.000 |
Why?
|
|
Ecker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|